Picture of Arecor Therapeutics logo

AREC — Arecor Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Arecor Therapeutics Says Cash Position At June 30 Of 8.2 Mln Stg

July 20 (Reuters) - Arecor Therapeutics PLC  AREC.L :
    * ARECOR BUSINESS UPDATE
    * GROUP'S UNAUDITED CASH POSITION AT 30 JUNE 2023 WAS £8.2
MILLION
    * LATER THIS YEAR EXPECT KEY DATA FOR AT278, ANTICIPATE
FURTHER
VALUE INFLECTION POINTS WITHIN OUR LICENSED PRODUCT PORTFOLIO
    * SECOND PHASE I CLINICAL TRIAL OF AT278 IN TYPE 2 DIABETIC
PATIENTS IS SCHEDULED TO COMPLETE WITHIN Q4

Source text for Eikon:  ID:nRST5821Ga 
Further company coverage:  AREC.L 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Arecor Therapeutics

See all news